Droplet Actuator Segmentation for PCR Cross-Contamination

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Droplet actuators face challenges in reducing cross-contamination between droplets during nucleic acid amplification and detection processes, particularly in PCR techniques, due to components exiting droplets into filler fluids and contaminating other droplets.

Innovation Solution

The method involves creating subsets of nucleic acid amplification reaction droplets, each treated under different conditions, with thermal cycling between multiple thermal zones using electrode-mediated droplet operations, and subsequent detection with reagents to minimize cross-contamination and optimize amplification and detection.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If droplet operations are conducted in a filler fluid environment, then droplet manipulation and thermal cycling can be performed, but cross-contamination occurs as components exit droplets into the filler fluid and contaminate other droplets

Engineering Contradiction:
Improvedroplet manipulationVSAvoidcross-contamination
Core Design Contradiction:
Ease of operationVSObject-affected harmful factors

Solution Approach 1:

The invention divides the droplet actuator into multiple isolated reaction chambers, each containing individual droplets. Physical barriers (walls) separate these chambers to prevent filler fluid-mediated cross-contamination while allowing independent thermal cycling and manipulation of each droplet. This segmentation maintains ease of operation through electrode-mediated control while eliminating the harmful cross-contamination effect.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention introduces an intermediate physical barrier (chamber wall) between droplets that blocks the transmission of contaminants through the filler fluid. This intermediary structure prevents direct interaction between filler fluids in different reaction chambers, thereby stopping cross-contamination while preserving the ability to perform droplet operations within each isolated chamber.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Productivity

If multiple droplets are processed simultaneously in the same chamber, then throughput increases, but cross-contamination between droplets increases

Engineering Contradiction:
ImprovethroughputVSAvoidcross-contamination
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The invention creates multiple independent reaction chambers arranged in parallel, each capable of processing individual droplets simultaneously. This segmentation allows high throughput across the entire device while maintaining isolation within each chamber to prevent cross-contamination. Each chamber functions as an independent processing unit.

Inventive Principle:
Principle #1Segmentation

3Temperature

If droplets are thermal cycled in a shared filler fluid environment, then thermal processing can be performed, but amplification efficiency decreases due to cross-contamination

Engineering Contradiction:
Improvethermal cyclingVSAvoidamplification efficiency
Core Design Contradiction:
TemperatureVSReliability

Solution Approach 1:

The invention provides separate thermal cycling capability for each isolated reaction chamber while maintaining physical barriers between chambers. This allows reliable nucleic acid amplification in each droplet without cross-contamination from neighboring droplets, preserving amplification efficiency. The segmented design enables parallel thermal processing across multiple chambers.

Inventive Principle:
Principle #1Segmentation

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach effectively reduces cross-contamination, enhances the amplification and detection of target nucleic acids, and allows for precise quantification of the target nucleic acid present in the sample.

Implementation Method 1

electrodes for conducting droplet operations

Methodology Applied
Scientific EffectElectrowetting: Electrowetting

Implementation Method 2

electrode mediated droplet operations

Methodology Applied
Scientific EffectElectrostatic forces: Electrostatics

Implementation Method 3

thermal cycling between multiple thermal zones

Methodology Applied
Scientific EffectThermal cycling:

Implementation Method 4

treating two or more subsets of the amplification reaction droplets under conditions for amplifying the target nucleic acid

Methodology Applied
Scientific EffectHeating: Heating

Implementation Method 5

amplifying the target nucleic acid to yield corresponding subsets of amplified droplets with amplified nucleic acid

Methodology Applied
Scientific EffectNucleic acid amplification:

Data Source

PatentUS8137917B2Droplet actuator devices, systems, and methods
Publication Date: 2012.03.20 ADVANCED LIQUID LOGIC INC
  • US8137917B2 patent drawing
  • US8137917B2 patent drawing
  • US8137917B2 patent drawing

AI summary

The invention relates to certain novel approaches to reducing or eliminating the movement of contaminants from one droplet to another on a droplet actuator via liquid filler fluid. In one application, droplet actuators are used to conduct genetic analysis using polymerase chain reaction (PCR) techniques. The invention addresses the need for improved methods of performing PCR on a droplet actuator that provide for optimum amplification and detection of a sample target.